nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—ABCB1—colon cancer	0.483	1	CbGaD
Fexofenadine—SLCO1B1—Irinotecan—colon cancer	0.127	0.271	CbGbCtD
Fexofenadine—SLCO1B3—Methotrexate—colon cancer	0.115	0.246	CbGbCtD
Fexofenadine—SLCO1A2—Methotrexate—colon cancer	0.071	0.152	CbGbCtD
Fexofenadine—SLCO1B1—Methotrexate—colon cancer	0.0669	0.144	CbGbCtD
Fexofenadine—ABCB1—Irinotecan—colon cancer	0.0362	0.0777	CbGbCtD
Fexofenadine—ABCB1—Vincristine—colon cancer	0.0317	0.0679	CbGbCtD
Fexofenadine—ABCB1—Methotrexate—colon cancer	0.0192	0.0411	CbGbCtD
Fexofenadine—Chest tightness—Capecitabine—colon cancer	0.00135	0.0312	CcSEcCtD
Fexofenadine—Accidental injury—Irinotecan—colon cancer	0.00107	0.0247	CcSEcCtD
Fexofenadine—Lomitapide—ABCB1—colon cancer	0.00106	0.515	CrCbGaD
Fexofenadine—Otitis media—Capecitabine—colon cancer	0.000815	0.0188	CcSEcCtD
Fexofenadine—Rhinorrhoea—Capecitabine—colon cancer	0.000783	0.0181	CcSEcCtD
Fexofenadine—Injury—Irinotecan—colon cancer	0.000749	0.0173	CcSEcCtD
Fexofenadine—Chest discomfort—Capecitabine—colon cancer	0.000717	0.0165	CcSEcCtD
Fexofenadine—Pain in extremity—Vincristine—colon cancer	0.000707	0.0163	CcSEcCtD
Fexofenadine—Nasopharyngitis—Fluorouracil—colon cancer	0.000589	0.0136	CcSEcCtD
Fexofenadine—Dry eye—Capecitabine—colon cancer	0.000586	0.0135	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Irinotecan—colon cancer	0.000553	0.0127	CcSEcCtD
Fexofenadine—Ear pain—Capecitabine—colon cancer	0.00054	0.0124	CcSEcCtD
Fexofenadine—Sleep disorder—Capecitabine—colon cancer	0.000532	0.0123	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Fluorouracil—colon cancer	0.000529	0.0122	CcSEcCtD
Fexofenadine—Increased appetite—Capecitabine—colon cancer	0.00049	0.0113	CcSEcCtD
Fexofenadine—Atrial fibrillation—Capecitabine—colon cancer	0.000486	0.0112	CcSEcCtD
Fexofenadine—Thirst—Capecitabine—colon cancer	0.000484	0.0112	CcSEcCtD
Fexofenadine—Epistaxis—Fluorouracil—colon cancer	0.000479	0.011	CcSEcCtD
Fexofenadine—Sinusitis—Fluorouracil—colon cancer	0.000477	0.011	CcSEcCtD
Fexofenadine—Pain in extremity—Capecitabine—colon cancer	0.000461	0.0106	CcSEcCtD
Fexofenadine—Flushing—Irinotecan—colon cancer	0.000442	0.0102	CcSEcCtD
Fexofenadine—SLCO1B3—vagina—colon cancer	0.00044	0.0838	CbGeAlD
Fexofenadine—Nasopharyngitis—Capecitabine—colon cancer	0.000412	0.0095	CcSEcCtD
Fexofenadine—Back pain—Vincristine—colon cancer	0.000412	0.00949	CcSEcCtD
Fexofenadine—Flatulence—Irinotecan—colon cancer	0.000408	0.00942	CcSEcCtD
Fexofenadine—Back pain—Irinotecan—colon cancer	0.000401	0.00924	CcSEcCtD
Fexofenadine—Agitation—Vincristine—colon cancer	0.000391	0.00902	CcSEcCtD
Fexofenadine—Abdominal discomfort—Capecitabine—colon cancer	0.000382	0.0088	CcSEcCtD
Fexofenadine—Vision blurred—Fluorouracil—colon cancer	0.000374	0.00863	CcSEcCtD
Fexofenadine—SLCO1B3—liver—colon cancer	0.000372	0.0707	CbGeAlD
Fexofenadine—Upper respiratory tract infection—Capecitabine—colon cancer	0.00037	0.00853	CcSEcCtD
Fexofenadine—Myalgia—Vincristine—colon cancer	0.000362	0.00835	CcSEcCtD
Fexofenadine—Cough—Irinotecan—colon cancer	0.000362	0.00834	CcSEcCtD
Fexofenadine—SLCO1B1—renal system—colon cancer	0.000352	0.0669	CbGeAlD
Fexofenadine—Anaphylactic shock—Vincristine—colon cancer	0.000347	0.00801	CcSEcCtD
Fexofenadine—Infection—Vincristine—colon cancer	0.000345	0.00796	CcSEcCtD
Fexofenadine—Anaphylactic shock—Irinotecan—colon cancer	0.000338	0.0078	CcSEcCtD
Fexofenadine—Myalgia—Fluorouracil—colon cancer	0.000338	0.00779	CcSEcCtD
Fexofenadine—Infection—Irinotecan—colon cancer	0.000336	0.00775	CcSEcCtD
Fexofenadine—Epistaxis—Capecitabine—colon cancer	0.000335	0.00772	CcSEcCtD
Fexofenadine—Anaphylactic shock—Fluorouracil—colon cancer	0.000324	0.00747	CcSEcCtD
Fexofenadine—Infection—Fluorouracil—colon cancer	0.000322	0.00742	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000316	0.0073	CcSEcCtD
Fexofenadine—Tachycardia—Fluorouracil—colon cancer	0.000316	0.00729	CcSEcCtD
Fexofenadine—Insomnia—Vincristine—colon cancer	0.000314	0.00724	CcSEcCtD
Fexofenadine—SLCO2B1—renal system—colon cancer	0.000311	0.0592	CbGeAlD
Fexofenadine—Insomnia—Irinotecan—colon cancer	0.000306	0.00705	CcSEcCtD
Fexofenadine—Dyspnoea—Irinotecan—colon cancer	0.000302	0.00695	CcSEcCtD
Fexofenadine—Pimozide—ABCB1—colon cancer	0.000301	0.147	CrCbGaD
Fexofenadine—Somnolence—Irinotecan—colon cancer	0.000301	0.00693	CcSEcCtD
Fexofenadine—Fatigue—Vincristine—colon cancer	0.000299	0.0069	CcSEcCtD
Fexofenadine—Dyspepsia—Irinotecan—colon cancer	0.000298	0.00687	CcSEcCtD
Fexofenadine—Pain—Vincristine—colon cancer	0.000297	0.00685	CcSEcCtD
Fexofenadine—Flushing—Capecitabine—colon cancer	0.000296	0.00682	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000295	0.00681	CcSEcCtD
Fexofenadine—Insomnia—Fluorouracil—colon cancer	0.000293	0.00676	CcSEcCtD
Fexofenadine—Fatigue—Irinotecan—colon cancer	0.000292	0.00672	CcSEcCtD
Fexofenadine—Pain—Irinotecan—colon cancer	0.000289	0.00667	CcSEcCtD
Fexofenadine—Dyspnoea—Fluorouracil—colon cancer	0.000289	0.00666	CcSEcCtD
Fexofenadine—SLCO1B1—digestive system—colon cancer	0.000288	0.0549	CbGeAlD
Fexofenadine—Somnolence—Fluorouracil—colon cancer	0.000288	0.00664	CcSEcCtD
Fexofenadine—SLCO1A2—renal system—colon cancer	0.000286	0.0545	CbGeAlD
Fexofenadine—Dyspepsia—Fluorouracil—colon cancer	0.000285	0.00658	CcSEcCtD
Fexofenadine—Abdominal discomfort—Methotrexate—colon cancer	0.000284	0.00655	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Vincristine—colon cancer	0.000284	0.00655	CcSEcCtD
Fexofenadine—Pain—Fluorouracil—colon cancer	0.000277	0.00639	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Irinotecan—colon cancer	0.000277	0.00638	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Methotrexate—colon cancer	0.000275	0.00635	CcSEcCtD
Fexofenadine—Abdominal pain—Vincristine—colon cancer	0.000275	0.00633	CcSEcCtD
Fexofenadine—Body temperature increased—Vincristine—colon cancer	0.000275	0.00633	CcSEcCtD
Fexofenadine—Flatulence—Capecitabine—colon cancer	0.000273	0.0063	CcSEcCtD
Fexofenadine—Back pain—Capecitabine—colon cancer	0.000268	0.00619	CcSEcCtD
Fexofenadine—Body temperature increased—Irinotecan—colon cancer	0.000267	0.00617	CcSEcCtD
Fexofenadine—Abdominal pain—Irinotecan—colon cancer	0.000267	0.00617	CcSEcCtD
Fexofenadine—Drowsiness—Methotrexate—colon cancer	0.000264	0.00609	CcSEcCtD
Fexofenadine—Vision blurred—Capecitabine—colon cancer	0.000261	0.00603	CcSEcCtD
Fexofenadine—Fentanyl—ABCB1—colon cancer	0.000261	0.127	CrCbGaD
Fexofenadine—Urticaria—Fluorouracil—colon cancer	0.000257	0.00593	CcSEcCtD
Fexofenadine—Body temperature increased—Fluorouracil—colon cancer	0.000256	0.00591	CcSEcCtD
Fexofenadine—Hypersensitivity—Vincristine—colon cancer	0.000256	0.0059	CcSEcCtD
Fexofenadine—SLCO2B1—digestive system—colon cancer	0.000255	0.0485	CbGeAlD
Fexofenadine—Loperamide—ABCB1—colon cancer	0.000251	0.123	CrCbGaD
Fexofenadine—Epistaxis—Methotrexate—colon cancer	0.000249	0.00575	CcSEcCtD
Fexofenadine—Hypersensitivity—Irinotecan—colon cancer	0.000249	0.00575	CcSEcCtD
Fexofenadine—Asthenia—Vincristine—colon cancer	0.000249	0.00575	CcSEcCtD
Fexofenadine—Palpitations—Capecitabine—colon cancer	0.000245	0.00565	CcSEcCtD
Fexofenadine—Asthenia—Irinotecan—colon cancer	0.000243	0.0056	CcSEcCtD
Fexofenadine—Cough—Capecitabine—colon cancer	0.000242	0.00558	CcSEcCtD
Fexofenadine—Hypersensitivity—Fluorouracil—colon cancer	0.000239	0.0055	CcSEcCtD
Fexofenadine—Diarrhoea—Vincristine—colon cancer	0.000238	0.00548	CcSEcCtD
Fexofenadine—Myalgia—Capecitabine—colon cancer	0.000236	0.00545	CcSEcCtD
Fexofenadine—SLCO1A2—digestive system—colon cancer	0.000235	0.0447	CbGeAlD
Fexofenadine—Diarrhoea—Irinotecan—colon cancer	0.000231	0.00534	CcSEcCtD
Fexofenadine—Dry mouth—Capecitabine—colon cancer	0.000231	0.00533	CcSEcCtD
Fexofenadine—Dizziness—Vincristine—colon cancer	0.00023	0.0053	CcSEcCtD
Fexofenadine—Pruritus—Fluorouracil—colon cancer	0.000229	0.00529	CcSEcCtD
Fexofenadine—Infection—Capecitabine—colon cancer	0.000225	0.00519	CcSEcCtD
Fexofenadine—Dizziness—Irinotecan—colon cancer	0.000224	0.00516	CcSEcCtD
Fexofenadine—Diarrhoea—Fluorouracil—colon cancer	0.000222	0.00511	CcSEcCtD
Fexofenadine—Tachycardia—Capecitabine—colon cancer	0.000221	0.00509	CcSEcCtD
Fexofenadine—Vomiting—Vincristine—colon cancer	0.000221	0.00509	CcSEcCtD
Fexofenadine—Rash—Vincristine—colon cancer	0.000219	0.00505	CcSEcCtD
Fexofenadine—Dermatitis—Vincristine—colon cancer	0.000219	0.00505	CcSEcCtD
Fexofenadine—Headache—Vincristine—colon cancer	0.000218	0.00502	CcSEcCtD
Fexofenadine—Vomiting—Irinotecan—colon cancer	0.000215	0.00496	CcSEcCtD
Fexofenadine—SLCO1B1—liver—colon cancer	0.000215	0.0409	CbGeAlD
Fexofenadine—Dizziness—Fluorouracil—colon cancer	0.000214	0.00494	CcSEcCtD
Fexofenadine—Rash—Irinotecan—colon cancer	0.000213	0.00492	CcSEcCtD
Fexofenadine—Dermatitis—Irinotecan—colon cancer	0.000213	0.00491	CcSEcCtD
Fexofenadine—ABCB1—blood vessel—colon cancer	0.000212	0.0404	CbGeAlD
Fexofenadine—Headache—Irinotecan—colon cancer	0.000212	0.00489	CcSEcCtD
Fexofenadine—Nausea—Vincristine—colon cancer	0.000206	0.00476	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000206	0.00476	CcSEcCtD
Fexofenadine—Vomiting—Fluorouracil—colon cancer	0.000206	0.00475	CcSEcCtD
Fexofenadine—Insomnia—Capecitabine—colon cancer	0.000205	0.00472	CcSEcCtD
Fexofenadine—Rash—Fluorouracil—colon cancer	0.000204	0.00471	CcSEcCtD
Fexofenadine—Dermatitis—Fluorouracil—colon cancer	0.000204	0.00471	CcSEcCtD
Fexofenadine—Headache—Fluorouracil—colon cancer	0.000203	0.00468	CcSEcCtD
Fexofenadine—Dyspnoea—Capecitabine—colon cancer	0.000202	0.00465	CcSEcCtD
Fexofenadine—Nausea—Irinotecan—colon cancer	0.000201	0.00463	CcSEcCtD
Fexofenadine—Back pain—Methotrexate—colon cancer	0.0002	0.00461	CcSEcCtD
Fexofenadine—Dyspepsia—Capecitabine—colon cancer	0.000199	0.0046	CcSEcCtD
Fexofenadine—Fatigue—Capecitabine—colon cancer	0.000195	0.0045	CcSEcCtD
Fexofenadine—Vision blurred—Methotrexate—colon cancer	0.000195	0.00449	CcSEcCtD
Fexofenadine—Pain—Capecitabine—colon cancer	0.000194	0.00446	CcSEcCtD
Fexofenadine—Nausea—Fluorouracil—colon cancer	0.000192	0.00444	CcSEcCtD
Fexofenadine—SLCO2B1—liver—colon cancer	0.00019	0.0362	CbGeAlD
Fexofenadine—HRH1—epithelium—colon cancer	0.000189	0.0359	CbGeAlD
Fexofenadine—Gastrointestinal pain—Capecitabine—colon cancer	0.000185	0.00427	CcSEcCtD
Fexofenadine—HRH1—smooth muscle tissue—colon cancer	0.000182	0.0346	CbGeAlD
Fexofenadine—Cough—Methotrexate—colon cancer	0.00018	0.00416	CcSEcCtD
Fexofenadine—Urticaria—Capecitabine—colon cancer	0.00018	0.00415	CcSEcCtD
Fexofenadine—Methadone—ABCB1—colon cancer	0.000179	0.0874	CrCbGaD
Fexofenadine—Body temperature increased—Capecitabine—colon cancer	0.000179	0.00413	CcSEcCtD
Fexofenadine—Abdominal pain—Capecitabine—colon cancer	0.000179	0.00413	CcSEcCtD
Fexofenadine—Myalgia—Methotrexate—colon cancer	0.000176	0.00405	CcSEcCtD
Fexofenadine—SLCO1A2—liver—colon cancer	0.000175	0.0333	CbGeAlD
Fexofenadine—Anaphylactic shock—Methotrexate—colon cancer	0.000169	0.00389	CcSEcCtD
Fexofenadine—Infection—Methotrexate—colon cancer	0.000167	0.00386	CcSEcCtD
Fexofenadine—Hypersensitivity—Capecitabine—colon cancer	0.000167	0.00385	CcSEcCtD
Fexofenadine—Asthenia—Capecitabine—colon cancer	0.000162	0.00375	CcSEcCtD
Fexofenadine—Pruritus—Capecitabine—colon cancer	0.00016	0.00369	CcSEcCtD
Fexofenadine—Diarrhoea—Capecitabine—colon cancer	0.000155	0.00357	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000154	0.00354	CcSEcCtD
Fexofenadine—Insomnia—Methotrexate—colon cancer	0.000152	0.00351	CcSEcCtD
Fexofenadine—Dyspnoea—Methotrexate—colon cancer	0.00015	0.00346	CcSEcCtD
Fexofenadine—Somnolence—Methotrexate—colon cancer	0.00015	0.00345	CcSEcCtD
Fexofenadine—Dizziness—Capecitabine—colon cancer	0.00015	0.00345	CcSEcCtD
Fexofenadine—Dyspepsia—Methotrexate—colon cancer	0.000148	0.00342	CcSEcCtD
Fexofenadine—SLCO2B1—lymph node—colon cancer	0.000146	0.0277	CbGeAlD
Fexofenadine—Fatigue—Methotrexate—colon cancer	0.000145	0.00335	CcSEcCtD
Fexofenadine—Pain—Methotrexate—colon cancer	0.000144	0.00332	CcSEcCtD
Fexofenadine—Vomiting—Capecitabine—colon cancer	0.000144	0.00332	CcSEcCtD
Fexofenadine—HRH1—digestive system—colon cancer	0.000144	0.0273	CbGeAlD
Fexofenadine—Rash—Capecitabine—colon cancer	0.000143	0.00329	CcSEcCtD
Fexofenadine—Dermatitis—Capecitabine—colon cancer	0.000143	0.00329	CcSEcCtD
Fexofenadine—Headache—Capecitabine—colon cancer	0.000142	0.00327	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Methotrexate—colon cancer	0.000138	0.00318	CcSEcCtD
Fexofenadine—Nausea—Capecitabine—colon cancer	0.000134	0.0031	CcSEcCtD
Fexofenadine—Urticaria—Methotrexate—colon cancer	0.000134	0.00309	CcSEcCtD
Fexofenadine—CYP2D6—renal system—colon cancer	0.000133	0.0254	CbGeAlD
Fexofenadine—Abdominal pain—Methotrexate—colon cancer	0.000133	0.00307	CcSEcCtD
Fexofenadine—Body temperature increased—Methotrexate—colon cancer	0.000133	0.00307	CcSEcCtD
Fexofenadine—HRH1—vagina—colon cancer	0.000127	0.0241	CbGeAlD
Fexofenadine—ABCB1—embryo—colon cancer	0.000127	0.0241	CbGeAlD
Fexofenadine—Hypersensitivity—Methotrexate—colon cancer	0.000124	0.00286	CcSEcCtD
Fexofenadine—Asthenia—Methotrexate—colon cancer	0.000121	0.00279	CcSEcCtD
Fexofenadine—Pruritus—Methotrexate—colon cancer	0.000119	0.00275	CcSEcCtD
Fexofenadine—Diarrhoea—Methotrexate—colon cancer	0.000115	0.00266	CcSEcCtD
Fexofenadine—Dizziness—Methotrexate—colon cancer	0.000111	0.00257	CcSEcCtD
Fexofenadine—CYP2D6—digestive system—colon cancer	0.000109	0.0208	CbGeAlD
Fexofenadine—Vomiting—Methotrexate—colon cancer	0.000107	0.00247	CcSEcCtD
Fexofenadine—Rash—Methotrexate—colon cancer	0.000106	0.00245	CcSEcCtD
Fexofenadine—Dermatitis—Methotrexate—colon cancer	0.000106	0.00245	CcSEcCtD
Fexofenadine—Headache—Methotrexate—colon cancer	0.000106	0.00243	CcSEcCtD
Fexofenadine—ABCB1—epithelium—colon cancer	0.000103	0.0197	CbGeAlD
Fexofenadine—Nausea—Methotrexate—colon cancer	0.0001	0.00231	CcSEcCtD
Fexofenadine—ABCB1—renal system—colon cancer	9.59e-05	0.0182	CbGeAlD
Fexofenadine—HRH1—lymph node—colon cancer	8.21e-05	0.0156	CbGeAlD
Fexofenadine—CYP2D6—liver—colon cancer	8.14e-05	0.0155	CbGeAlD
Fexofenadine—ABCB1—lymphoid tissue—colon cancer	7.96e-05	0.0151	CbGeAlD
Fexofenadine—ABCB1—digestive system—colon cancer	7.86e-05	0.015	CbGeAlD
Fexofenadine—ABCB1—bone marrow—colon cancer	7.25e-05	0.0138	CbGeAlD
Fexofenadine—ABCB1—vagina—colon cancer	6.94e-05	0.0132	CbGeAlD
Fexofenadine—ABCB1—liver—colon cancer	5.86e-05	0.0111	CbGeAlD
Fexofenadine—ABCB1—lymph node—colon cancer	4.49e-05	0.00855	CbGeAlD
